Effects of Propolis Capsule on Human Hyperlipidemia
Dong Jie
Abstract
Dong Jie
Abstract
Through self-control and inter-group control, the volunteers according with conditions took propolis capsule orally, and after 59-d duration the blood lipid reducing effects of the propolis capsule were studied. The experimental results indicated that the difference between CHOL and TG is significant (p0.05), with the decreases of 10.10% and 18.09% respectively. The CHOL and TG of the test group are remarkably different (p0.05) from the control group. The HDL-C shows no significant difference (p0.05) between the test group and the control group. No obriously adverse effects are found in the human experiments.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Through self-control and inter-group control, the volunteers according with conditions took propolis capsule orally, and after 59-d duration the blood lipid reducing effects of the propolis capsule were studied. The experimental results indicated that the difference between CHOL and TG is significant (p0.05), with the decreases of 10.10% and 18.09% respectively. The CHOL and TG of the test group are remarkably different (p0.05) from the control group. The HDL-C shows no significant difference (p0.05) between the test group and the control group. No obriously adverse effects are found in the human experiments.
Key concepts: Propolis, Capsule, Hyperlipidemia, Positive control, Significant difference, Blood lipids, Chemistry, Medicine